areta's aim is to satisfy its customer needs during the various stages of the development of a biological drug with custom-made and high-quality production by means of single-use and modular bioreactors, ideal for this type of pharmaceutical products.

The single-use bioreactors are cell culture systems, both for mammalian and bacterial cells, easy to handle and flexible, ideal with respect to safety and in accordance with GMP requirements.
They are particularly advantageous in production and development processes, both in R&D and GMP.

areta evaluates and chooses the bioreactor which is most suitable for the cell's physiology and then build a robust and optimized process, focusing on speed and high yields. The single-use bioreactors' flexibility, together with a modular production approach, enable areta to generate customized processes within a wide range of volumes, ensuring a high level of purity and quality to the finished product.

areta thus satisfies the various production requirements and guarantees competitive costs, avoiding the need for expensive investments during the project's preliminary phases.

Moreover, the use of the modular approach allows for a much simpler and faster process scale-up, thus avoiding the need for further process development activities.

In the GMP field, the use of single-use bioreactors eliminates the necessity of the cleaning validation procedures, cutting related costs and Roller bottleallowing for the management of a faster turnover of the production runs.